Compound ID | 886
Class: Quinoline-indole
Spectrum of activity: | Gram-negative |
Details of activity: | Lysis followed bacteria death, thought to be related to membrane damage |
Institute where first reported: | Sepracor (Sunovion Pharmaceuticals, Inc) |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|